pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·23h ago·1 min read
save

MHRA AI Commission Issues 44 Recommendations for Future UK Regulatory Framework

Sep 17, 2026·read at raps ↗RegulatoryNeutral

A commission established by the Medicines and Healthcare products Regulatory Agency has released its findings.

The group presented 44 recommendations aimed at shaping the United Kingdom’s regulatory approach to artificial intelligence in medicines and health products.

The proposals are intended to guide future policy, offering a framework that could affect how AI-driven tools are evaluated and approved in the UK market.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Euro Roundup: MHRA commission makes recommendations on AI regulatory framework in the UK”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
The Medicines Co2

related stories

  • 2d agoStakeholders urge FDA to define data, treatment standards as psychedelic drugs near marketBioSpace
  • Sep 10Novartis shareholder calls for board overhaul following costly deal setbacks: ReutersFierce Biotech
  • Sep 2UK regulator halts sales of Tavneos; UniQure seeks approval for Huntington's gene therapyEndpoints
  • Aug 27Euro Roundup: MHRA updates guidance on submitting safety reports for UK productsraps
  • Aug 26STAT+: Pharmalittle: We’re reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and moreSTAT